Analystreport

GSK plc (NYSE: GSK) was upgraded by analysts at Argus to a "strong-buy" rating.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors